In reference 29 the author’s name is shown as 'Standardise MA', when it should be ‘Moore A’. Reference 41 is a duplicate of reference 42, therefore the original reference 41 is not shown. These references should read: 41. Hickson RP, Steinke DT, Skitterall C, et al. Evaluation of a pharmaceutical assessment screening tool to measure patient acuity and prioritise pharmaceutical care in a UK hosp...

Under 5 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27 5.4 5 to 9 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26 5.2 10 to 14 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 6.0 15 to 19 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41 8.3 20 to 24 years . . . . . . . . . . . . . . . . . . . . . . ....

................................................................................................5 Definitions and abbreviations ...............................................................6 Introduction ...........................................................................................7 Aim..................................................................................................

28 29 30 31 32 33 34 35 36 37 38 39 40 41 Article history: Received 21 April 2014 Received in revised form 23 October 2014 Accepted 27 January 2015 Available online xxxx

.........................................................................................................iii Chapter 1 – Introduction................................................................................................................1 Chapter 2 – Review of Literature............................................................................5 Chapter 3 Prefrontal Activation during E...

4 Limitations, Examples, and Literature Survey 29 4.1 Scope of the Momentum Construction . . . . . . . . . . . . . . . . . . . . . . . . . . 30 4.2 Line Bundles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35 4.3 Vector Bundles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38 4.4 Metrics of Finite Fibre Area . . . . . . . . . . ...

years; range 41-77 years. There were 16 (35.6%) male patients and 29(64.4%) female patients. Thirty-eight (84.4%) patients (40 eyes) had central retinal vein occlusion (CRVO), 7 (15.6%) patients (8 eyes) had branch vein occlusion (BRVO), and 29 (60.4%) eyes (all CRVO) had ischaemic vein occlusion. Twenty-eight (58.3%) eyes were blind, while 18 (37.5%) had visual impairment. Twenty-five (55.6%) ...

Under 5 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19 4.9 5 to 9 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 6.2 10 to 14 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 7.7 15 to 19 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 7.5 20 to 24 years . . . . . . . . . . . . . . . . . . . . . . ....

Hepatic manifestations are described as unusual complications of dengue and may lead to severe and potentially lethal conditions. Liver abnormalities in 41 patients diagnosed with dengue hemorrhagic fever in Campo Grande, Mato Grosso do Sul, Brazil, between January 1 and March 31, 2002, were evaluated. All were serologically positive for dengue in laboratory tests (IgM ELISA). ALT alterations w...